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A B S T R A C T
Objectives: Nasopharyngeal carriage of Streptococcus pneumoniae underpins disease development and
transmission. This study was performed to examine pneumococcal carriage dynamics, including density
and multiple serotype carriage, in Indonesian infants during the ﬁrst year of life.
Methods: Two hundred healthy infants were enrolled at 2 months of age. Eight nasopharyngeal swabs
were collected from enrolment until 12 months of age. Pneumococci were detected using quantitative
PCR and serotyped by microarray. Regression models assessed factors inﬂuencing pneumococcal carriage
and density.
Results: Eighty-ﬁve percent of infants carried pneumococci at least once during the study. The median age
at ﬁrst acquisition was 129 days (interquartile range 41–216 days). The median duration of carriage was
longer for the ﬁrst pneumococcal acquisition compared with subsequent acquisitions (151 days vs. 95
days, p < 0.0001). Of the 166 infants who carried pneumococci during the study, the majority (63.9%)
carried a single pneumococcal serotype at a time. Pneumococcal carriage density was higher when upper
respiratory tract infection symptoms were present, lower during antibiotic usage, decreased with age,
and tended to decrease over time during a carriage episode.
Conclusions: The majority of Indonesian infants carry pneumococcus at least once during the ﬁrst year of
life. Pneumococcal carriage is a dynamic process, with pneumococcal density varying during a carriage
episode.
© 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Introduction
Streptococcus pneumoniae (pneumococcus) can cause a variety of
diseases ranging from otitis media to pneumonia, meningitis, and
sepsis, and was responsible for an estimated 317 300 paediatric
deaths in 2015 (Wahl et al., 2018). Pneumococci commonly colonize
the nasopharynxof youngchildren, withcarriage prevalence ranging
from 19% to 86% (Adegbola et al., 2014). Carriage is considered an
essential ﬁrst step in the development of pneumococcal disease, and
is the source of transmissionwithin humanpopulations(Simell et al.,
2012). Pneumococcal conjugate vaccines (PCVs) reduce carriage by
blocking the acquisition of vaccine-serotype pneumococci,
protecting immunized children and resulting in potent indirect
effects by reducing transmission to unvaccinated individuals (Mitsi
et al., 2016).
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Data fromlongitudinalstudieshave demonstratedthatcarriage is
a dynamic process. The timing of acquisition and clearance is
inﬂuenced by factors including serotype, age, and previous
pneumococcal exposure (Hill et al., 2008; Turner et al., 2012;
Abdullahi et al., 2012). Young children commonly experience
multiple carriage episodes: a study in Thailand reported a median
of seven pneumococcal acquisitions during the ﬁrst 24 months of life
(Turner et al., 2012). High pneumococcal density in the nasopharynx
is associated with pneumonia in children, and linked to transmission
in animal studies (Vu et al., 2011; Short et al., 2012). Simultaneous
carriage of multiple pneumococcal serotypes is common in children
in low- and middle-income countries (Satzke et al., 2015). Few
published longitudinal carriage studies to date have examined
pneumococcal density or used methods capable of detecting
multiple serotype carriage. A detailed investigation of carriage
dynamics, including quantitative information on pneumococcal
densityand detection of co-colonizing serotypes, would improve our
understanding of this important process, and provide useful
information for estimating and evaluating vaccine effects.
A longitudinal study was conducted in Indonesia, a country
with no national PCV programme, to examine pneumococcal
carriage during the ﬁrst year of life. Indonesia has a high burden of
childhood pneumonia, which is the leading cause of death in
children outside the neonatal period, with an estimated incidence
of 326 per 1000 children per year in 2015 (UNICEF, 2014; McAllister
et al., 2019). Previous studies have reported pneumococcal carriage
prevalence ranging from 43% to 53% in young children in Indonesia
(Soewignjo et al., 2001; Hadinegoro et al., 2016; Farida et al., 2014;
Dunne et al., 2018). The aim of this study was to determine
pneumococcal carriage prevalence and density over time, and
investigate the dynamics of carriage, including acquisition,
duration, and multiple serotype carriage, using quantitative
molecular methods.
Methods
Study population, design, and procedures
This study was conducted in the Bandung region of West Java,
Indonesia. Indonesia is a lower middle-income country consisting
of over 17 000 islands, with a population of over 260 million. The
estimated case rate of pneumonia in Indonesian children is
approximately 5000 per 100 000 hospital discharges (Azmi et al.,
2016). Childhood mortality varies regionally and between urban
and rural settings (Hodge et al., 2014). Indonesian infants routinely
receive BCG, polio, HepB (birth dose), pentavalent (DTP–HepB–
Hib), and measles–rubella vaccination as part of the Expanded
Programme on Immunization.
Recruitment was conducted at two health centres, an urban
centre in Bandung city and a semi-rural centre located in the
Padalarang district approximately 25 km from Bandung city, from
November 2014 to January 2015. Mothers of newborns were
identiﬁed by community health workers and invited to have their
infant participate in the study. Written informed consent was
obtained from a parent/guardian prior to any study procedures.
Enrolment criteria included age of 8–12 weeks, weight >2500 g,
living within the study area and no plans to relocate during the
follow-up period, and judged to be in good health following
examination by a paediatrician. Exclusion criteria included
moderate/severe illness at the time of screening, axillary
temperature 38 C, antibiotic use within the previous 14 days,
prior hospitalization for conditions excluding jaundice, mother
with known HIV-positive status, and prior or expected PCV
immunization.
Data on demographic characteristics and household informa-
tion were collected by study staff at the initial visit. Six subsequent
visits were conducted monthly, and then a ﬁnal visit at 12 months
of age. Data on upper respiratory tract infection (URTI) symptoms
(rhinorrhoea, cough, or other respiratory symptoms), recent
antibiotic usage, breast feeding status, and major illnesses/
hospitalizations were collected at follow-up visits. At each visit,
a nasopharyngeal swab was collected according to World Health
Organization recommendations (Satzke et al., 2013).
The sample size was based on an estimated pneumococcal
carriage prevalence of 50% at 5 months of age (Soewignjo et al.,
2001). One hundred and twenty participants would estimate
carriage prevalence with conﬁdence intervals of 8.9%. The sample
size was increased to 200 to facilitate secondary analyses.
Ethical approval was granted by the Health Research Ethics
Committee, Universitas Padjadjaran Faculty of Medicine, Indonesia
(536/UN6.C2.1.2/KEPK/PN/2014) and the Royal Children’s Hospital
Human Research Ethics Committee, Australia (34124).
Laboratory analyses
Swabs were placed into 1 ml skim milk tryptone glucose
glycerol (STGG) medium, kept in a cool box, and transported to the
Microbiology Laboratory at the Advanced Biomedical Laboratory,
Faculty of Medicine, Universitas Padjadjaran, Bandung for aliquot-
ing and storage at 70 C within 8 h of collection. Pneumococci
were detected and serotyped as described previously (Dunne et al.,
2018). In brief, DNA extracted from STGG was examined by lytA
real-time quantitative PCR (qPCR) to detect pneumococci and
determine pneumococcal density, reported in genome equivalents
per millilitre (GE/ml) (Carvalho et al., 2007). Molecular serotyping
by microarray was conducted following a culture-ampliﬁcation
step, in which 50 ml of the neat sample and a 1:10 dilution were
plated on selective agar and incubated overnight. The plate
containing optimal growth of high-density, distinct colonies was
selected for DNA extraction. DNA was fragmented and ﬂuores-
cently labelled, and microarray was conducted using Senti-SP v1.6
(BUGS Bioscience), which reports the identity and relative
abundance (%) of all serotypes present within a sample (Satzke
et al., 2015). Previously, this method was found to have very high
sensitivity, including >93% sensitivity for the detection of
secondary serotypes present in low proportions in samples
containing multiple serotypes (Satzke et al., 2015). Serotype-
speciﬁc density was determined by multiplying pneumococcal
density (determined by qPCR) by the serotype relative abundance
(determined by microarray). A representative isolate from each
sample was serotyped by latex agglutination/Quellung.
Data analysis
Deﬁnitions of pneumococcal carriage episodes were based on
the identiﬁcation of an individual serotype, and estimates of dates
of acquisition (midpoint between last negative swab and ﬁrst
positive swab) and clearance (midpoint between last positive swab
and subsequent negative swab) were consistent with published
longitudinal carriage studies (Turner et al., 2012; Heinsbroek et al.,
2016; Dube et al., 2018; Tigoi et al., 2012). For infants carrying
pneumococci at enrolment, the date of acquisition was estimated
as the midpoint between birth and visit 1. Clinical data were
entered into a database (dBASE software; dBase LLC, Binghamton,
NY, USA) then merged with laboratory data and cleaned using Stata
version 14.2 (StataCorp, College Station, TX, USA). The statistical
analyses were conducted using Stata and GraphPad Prism version
7.03 (GraphPad Software, La Jolla, CA, USA).
Pneumococcal density data were log10 transformed prior to
analysis. The Chi-square test was used to compare categorical data
and the t-test or analysis of variance (ANOVA) for continuous data,
unless noted otherwise. Data on carriage prevalence, age at ﬁrst
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acquisition, and number of acquisitions were examined overall and
by residence type (urban vs. semi-rural). All other analyses used
overall data. Kaplan–Meier curves were used to examine time to
ﬁrst pneumococcal acquisition and the log-rank test to compare by
residence type. Multivariable Cox regression analysis was used to
assess whether the following factors were associated with time (in
days) to ﬁrst acquisition: residence type, ethnicity, two or more
children <5 years of age in the household, cigarette smoker in the
household, breast feeding, parental income, and maternal educa-
tion. Parametric survival models (Weibull distribution) were used
to assess carriage duration; carriage episodes that were ongoing at
the ﬁnal study visit were censored. Carriage episodes that were
ﬁrst detected at the ﬁnal study visit were excluded from analyses of
carriage duration. The log-rank test was used to compare carriage
duration for ﬁrst vs. subsequent acquisitions.
Logistic regression models were used to evaluate relationships
between age (months), antibiotic exposure, and presence of URTI
symptoms (variables selected a priori) and pneumococcal carriage,
incorporating generalized estimating equations (GEEs) with robust
95% conﬁdence intervals (CI) and an unstructured working
correlation matrix to account for repeated sampling of individuals.
GEE linear regression models were used to investigate associations
between overall pneumococcal density and age, antibiotic expo-
sure, URTI symptoms, and multiple serotype carriage. For longer
carriage episodes (serotype detected in 3 swabs), the detection
stages of carriage episode were deﬁned as initial (ﬁrst detection),
middle (subsequent detections), and ﬁnal (last detection prior to
clearance). To examine associations between stage of carriage
episode and serotype-speciﬁc density, a three-level linear random
intercept model was used, with repeated density measures nested
within serotypes and multiple serotypes nested within individuals
(to account for repeated sampling and multiple serotype carriage).
Covariates in the model included age, antibiotic exposure, URTI
symptoms, and multiple serotype carriage.
The dynamics of pneumococcal carriage were categorized into
ﬁve observed patterns: ‘single serotype carriage’ (carriage of a
single serotype at a time), ‘serotype replacement’ (an initial
colonizing serotype became outnumbered by a newly acquired
serotype and was subsequently cleared), ‘serotype dominance’
(carriage of an initial colonizing serotype was maintained and
newly acquired serotypes were transient), ‘stable co-colonization’
(two serotypes simultaneously carried across multiple time
points), and ‘short-term co-colonization’ (multiple serotype
carriage observed at a single time point).
Table 1
Characteristics of study participants at enrolment.a
Characteristic Total
(n = 200), n (%)
Urban
(n = 98), n (%)
Semi-rural
(n = 102), n (%)
Sex
Male 115 (57.5) 64 (65) 51 (50)
Female 85 (42.5) 34 (35) 51 (50)
Age (months)
Median (IQR) 2.1 (2.0, 2.3) 2.0 (2.0, 2.2) 2.2 (2.0, 2.5)
Weight (kg)
Median (IQR) 5.2 (4.8, 5.8) 5.2 (4.8, 5.8) 5.2 (4.8, 5.8)
Height (cm)
Median (IQR) 58 (57, 60) 58 (56, 60) 58 (57, 59)
Weight-for-length Z score
Median (IQR) 0.4 (1.2, 0.2) 0.4 (1.2, 0.1) 0.4 (1.2, 0.4)
Ethnicity
Sundanese 162 (81.0) 68 (69) 94 (92)
Javanese 35 (17.5) 29 (30) 6 (6)
Other 3 (1.5) 1 (1) 2 (2)
Paternal education
Elementary school 23 (11.5) 6 (6) 17 (17)
Junior high school 53 (26.5) 16 (16) 37 (37)
Senior high school 99 (49.5) 59 (60) 40 (39)
University 25 (12.5) 17 (17) 8 (8)
Maternal education
None 1 (0.5) 1 (1) 0 (0)
Elementary school 23 (11.5) 4 (4) 19 (19)
Junior high school 51 (25.5) 15 (15) 36 (35)
Senior high school 105 (52.5) 66 (67) 39 (38)
University 20 (10.0) 12 (12) 8 (8)
Parental monthly income
Declined to answer 2 (1.0) 1 (1) 1 (1)
 Regional minimum salaryb 159 (79.5) 73 (74) 86 (84)
> Regional minimum salary 39 (19.5) 24 (24) 15 (15)
Number of children <5 years old in the household
1 109 (54.5) 39 (39) 70 (69)
2 64 (32.0) 39 (39) 25 (24)
3 18 (9.0) 13 (13) 5 (5)
4 9 (4.5) 7 (7) 2 (2)
Cigarette smoker in the household
No 57 (28.5) 36 (37) 21 (21)
Yes 143 (71.5) 62 (63) 81 (79)
Breast feeding at 12 months
No 19/198 (9.6) 9/96 (9) 10/102 (9.8)
Yes 179/198 (90.4) 87/91 (94) 92/102 (90.2)
IQR, interquartile range.
a Chi-square test for categorical values, Mann–Whitney test for age, t-test for weight and height.
b Regional minimum salary rates for 2014 were 2 000 000 IDR/month for urban participants and 1 738 476 IDR/month for semi-rural participants.
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Results
A total of 200 infants were enrolled in the study. Characteristics
of the participants are shown in Table 1. During the study period,
there was one participant death (respiratory failure due to severe
bronchopneumonia plus suspected congenital rubella syndrome)
and two drop-outs, and three participants missed swab collection
visits. Eight participants were hospitalized with a diagnosis of
pneumonia.
A total of 1575 nasopharyngeal swabs were collected. Four
swabs were excluded due to technical issues. The overall
pneumococcal carriage prevalence was 22.0% (44/200; 95% CI
16.5–28.4%) at enrolment and increased to 68.4% (62/196; 95% CI
61.4–74.8%) at 12 months of age. Pneumococcal carriage rates are
shown by site and age in Figure 1. At 2 and 7 months of age,
pneumococcal carriage prevalence was higher in semi-rural
infants compared with those from urban areas (p = 0.01 and
p = 0.045, respectively).
Most of the infants (169/198, 85.4%) carried pneumococci at
least once during the study period. The median age at ﬁrst
acquisition was 129 days (interquartile range (IQR) 41–216
days). Figure 2 depicts the time to ﬁrst pneumococcal
acquisition for urban and semi-rural infants (p = 0.064). None
of the potential risk factors evaluated were associated with time to
ﬁrst acquisition; however there was some evidence that higher
parental income was associated with delayed ﬁrst acquisition
(p = 0.055, Supplementary material Table S1). The number of
pneumococcal acquisitions per child during the study period
ranged from 0 to 5, with a median of 1 (IQR 1–2) overall, 1 for
urban infants (IQR 1–2), and 2 (IQR 1–3) for semi-rural infants (p
= 0.061, Mann–Whitney test). A total of 318 pneumococcal
acquisitions occurred during 70 429 days at risk, an acquisition
rate of 0.0045 per day (95% CI 0.0040–0.0050 per day), or 0.14 per
month (95% CI 0.12–0.15 per month).
Antibiotic usage during the study period was reported at least
once for 54/198 (27.3%) study participants. Thirty-seven swabs
were collected from infants currently taking oral antibiotics, 13
(35%) of which were positive for pneumococcus; an additional 17
infants took antibiotics within 14 days of swab collection. Overall,
170 (85.6%) study participants had URTI symptoms during at least
one study visit, and 364 (23.1%) of the swabs were collected from
infants with current URTI symptoms. Current or recent antibiotic
usage was negatively associated with pneumococcal carriage,
whereas the presence of URTI symptoms was positively associated
(Table 2).
Pneumococci identiﬁed during the study period belonged to 46
capsular serotypes and four genetic variants of non-encapsulated
pneumococci (Salter et al., 2012). Thirty of 650 (4.6%) lytA-positive
samples were culture-negative and therefore not serotyped.
Serotypes 6B, NT2 (a non-encapsulated lineage), 19F, 23F, 34,
and 15B/C were the most common (Figure 3). All serotype 11A
pneumococci identiﬁed were typed as 11F-like variants by
microarray (Manna et al., 2018). One hundred and twenty-two
(38.4%) of the carriage episodes were due to serotypes included in
PCV13. The carriage prevalence of PCV13 serotypes, non-PCV13
serotypes, and non-encapsulated pneumococci over time is shown
in Supplementary material Figure S1. Carriage prevalence of PCV13
serotypes increased from 9.1% at enrolment to 35.1% at 12 months.
Overall, the median duration of carriage was 132 days (IQR 77–
217 days), ranging from 28 to 328 days. Four infants carried the
same pneumococcal serotype for the entire study duration. The
Figure 1. Pneumococcal carriage prevalence by age for infants living in urban and
semi-rural areas. Bars indicate 95% conﬁdence interval; *p < 0.05, Chi-square test.
Figure 2. Age (in days) at ﬁrst pneumococcal acquisition for infants living in urban
and semi-rural areas; p = 0.064, log-rank test.
Table 2
Logistic regression analysis of factors associated with pneumococcal carriage in
Indonesian infants during the ﬁrst year of life. Models incorporate generalized
estimating equations to account for repeated sampling (n = 1571).
OR (95% CI) p-Value aOR (95% CI) p-Value
Antibiotic exposurea 0.53 (0.33, 0.85) 0.009 0.44 (0.25, 0.78) 0.004
URTI symptoms 1.25 (1.06, 1.48) 0.010 1.21 (1.01, 1.46) 0.041
Age (months) 1.21 (1.17, 1.26) <0.001 1.22 (1.17, 1.27) <0.001
OR, odds ratio; aOR, adjusted odds ratio; CI, conﬁdence interval; URTI, upper
respiratory tract infection.
a Current and/or within the previous 14 days.
Figure 3. Pneumococcal carriage episodes by serotype. PCV13 serotypes are shown
in red (* indicates the three serotypes not included in PCV10), non-PCV13 capsular
serotypes are shown in black, and non-encapsulated pneumococci (categorized into
genetic variants (Salter et al., 2012) are shown in grey. ‘Other PCV13’ consists of
serotypes 1 and 7F (n = 2, each). ‘Other NVT’ consists of serotypes 8, 45, 17F, 23B (n
= 3 each), 38, 39, 18A, 19B, 28F, 35F, 7C (n = 2 each), and 40,10F, 12F, 15F, 17A, and 28A
(n = 1 each). ‘Other NESp’ consists of non-encapsulated lineages NT4b (n = 2) and
NT2/NT3b (n = 1).
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median carriage duration for the ﬁrst pneumococcal acquisition
was 158 days (IQR 84–260 days), compared with 95 days (IQR 56–
161 days) for subsequent acquisitions (p = 0.0013, log-rank test).
Pneumococcal density ranged from 2.33 to 8.76 log10 GE/ml, with a
mean of 6.04 log10 GE/ml (95% CI 5.96–6.11 log10 GE/ml).
Pneumococcal density is shown by age and site in Supplementary
material Figure S2. Density did not differ by site (p = 0.694, t-test)
and there was some evidence that density differed by age (p
= 0.066, one-way ANOVA). Regression analysis demonstrated that
in pneumococcal carriers, density was higher when URTI
symptoms were present and decreased with age, and there was
some evidence that density was lower in infants currently on
antibiotics (Table 3).
Multiple serotype carriage was observed in 98 samples (two
serotypes n = 93, three serotypes n = 5), and increased with age
(Supplementary material Figure S1). Fifty-nine of 198 participants
(29.8%) had multiple serotype carriage observed at least once.
Multiple serotype carriage was associated with higher overall
pneumococcal density (Table 3). During longer carriage episodes
(deﬁned as detected in 3 swabs), serotype-speciﬁc density
tended to decrease over time, with mean density higher at initial
detection (6.36 log10 GE/ml, 95% CI 6.18–6.53 log10 GE/ml)
compared with the ﬁnal detection prior to clearance (5.71 log10
GE/ml, 95% CI 5.47–5.95 log10 GE/ml) (Figure 4). In a multi-level
model including URTI symptoms, antibiotic use, multiple serotype
carriage, and age, density at ﬁnal detection was 0.62 log10 GE/ml
lower compared with initial detection (Table 4).
The carriage dynamics of the 166 participants who carried
pneumococci at least once were examined after excluding three
with no serotyping data. A representative example of each pattern
is shown in Figure 5. Single serotype carriage was the most
common (n = 106, 63.9%), followed by serotype replacement (n = 11,
6.6%) and serotype dominance (n = 10, 6.0%). Stable co-colonization
and short-term co-colonization were each observed in eight (4.8%)
participants. For 23 (13.8%) participants, no pattern was deter-
mined, as multiple serotype carriage was only observed at the ﬁnal
swab collection.
Discussion
At 12 months of age, 68% of Indonesian infants carried
pneumococcus, with a median age at acquisition of 129 days.
These ﬁndings reﬂect a setting of moderate pneumococcal carriage
intensity in comparison to longitudinal studies conducted in other
areas. In Finland, carriage prevalence peaked at 28% at 18 months
of age, and in the USA, the mean age at acquisition was 6 months
(Leino et al., 2001; Gray et al., 1980). In high carriage intensity
settings such as The Gambia, Kenya, South Africa, Malawi, and a
refugee camp in Thailand, median age at ﬁrst pneumococcal
acquisition ranged from 33 to 63 days (Hill et al., 2008; Turner
et al., 2012; Heinsbroek et al., 2016; Dube et al., 2018; Tigoi et al.,
2012). In these settings, pneumococcal carriage prevalence peaked
by 6 months, for example reaching 64% in South Africa and 80% in
Thailand, whereas in Indonesia carriage prevalence continued to
rise until 12 months of age (Turner et al., 2012; Dube et al., 2018).
We previously reported a pneumococcal carriage prevalence of
64% in children aged 12–24 months old in the Bandung region,
suggesting that carriage rates stabilize after 12 months in this
population (Dunne et al., 2018). Carriage prevalence tended to be
higher in infants living in semi-rural areas than in urban residents,
as observed in some, but not all, other studies (Hanieh et al., 2014;
Nisar et al., 2018). Previously, we did not observe differences in
pneumococcal carriage between urban and semi-rural Indonesian
children aged 12–24 months, suggesting that differences diminish
with age (Fadlyana et al., 2018).
Data from Indonesia could inform models for pneumococcal
vaccine trials in similar settings, particularly in Asia, where PCV
introduction has lagged behind other regions (Tricarico et al., 2017;
Cai et al., 2018). Data on serotypes causing invasive pneumococcal
disease in Indonesia are extremely limited, a major knowledge gap
for this country. It was therefore not possible to correlate carriage
data with serotypes causing disease. Modelling approaches have
used carriage data to predict serotypes causing invasive disease
and vaccine impact and may be an avenue for future investigation
(Weinberger et al., 2011; Flasche et al., 2015).
Table 3
Linear regression analysis of factors associated with pneumococcal carriage density in pneumococcal-positive samples (n = 680). Models incorporate generalized estimating
equations to account for repeated sampling.
Unadjusted coefﬁcienta (95% CI) p-Value Adjusted coefﬁcient
(95% CI)
p-Value
Current antibiotic useb 0.56 (1.07, 0.05) 0.031 0.74 (1.51, 0.03) 0.059
URTI symptoms 0.27 (0.10, 0.44) 0.002 0.31 (0.15, 0.46) <0.001
Age (months) 0.03 (0.06, 0.01) 0.010 0.04 (0.06, 0.01) 0.005
Multiple serotype carriage 0.18 (0.00, 0.37) 0.051 0.26 (0.06, 0.46) 0.011
CI, conﬁdence interval; URTI, upper respiratory tract infection.
a Coefﬁcient is the difference in means (log10 genome equivalents/ml). For example, infants on antibiotics at the time of swabbing had a mean pneumococcal density 0.56
log10 lower than those not currently using antibiotics, whereas infants with URTI symptoms had a mean pneumococcal density 0.27 log10 higher than those without URTI
symptoms. For each month increase in age, the mean pneumococcal density decreased by 0.03 log10.
b Antibiotic use at the time of swabbing.
Figure 4. Serotype-speciﬁc pneumococcal carriage density (in log10 genome
equivalents/ml) shown by stage of carriage episode, for episodes that were detected
in 3 swabs. Detection stages deﬁned as initial detection, middle (subsequent
detections), and ﬁnal (last detection prior to clearance). Bars indicate mean  95%
conﬁdence interval; p < 0.0001, one-way ANOVA.
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It was found in this study that the duration of carriage was
longer for initial pneumococcal acquisitions than for subsequent
acquisitions, regardless of serotype. Although maturation of the
immune system with age likely contributes to this effect, it is
recognized that pneumococcal colonization is immunizing
(Jochems et al., 2017). Epidemiological evidence suggests that
both serotype-speciﬁc and serotype-independent immunity are
generated by pneumococcal carriage. In Bangladesh, acquisition
rates of the four most common serotypes were lower in children
who had previously experienced carriage of a heterologous
serotype, suggestive of serotype-independent immunity (Granat
Simo et al., 2009). In Thailand, the interval to reacquisition of
common serotypes was longer in children who had previously
carried either homologous or heterologous serotypes, and the
carriage duration of serotypes 14 and 19F was shorter when
reacquired following homologous carriage (Turner et al., 2012).
Serotype 6B, which was the most commonly acquired serotype
in the current study, was not among the 10 most common
serotypes carried by children aged 12–24 months in Bandung,
suggesting that carriage of serotype 6B during infancy may
generate a serotype-speciﬁc immune response that is protective
in later childhood (Dunne et al., 2018). A study in Israeli toddlers
found that children who had previously carried serotypes 14 and
23F had a reduced risk of subsequent carriage of those
serotypes, and protection correlated with increased levels of
serotype-speciﬁc antibodies (Weinberger et al., 2008). Further
investigation of the immune responses induced by carriage,
particularly those that contribute to serotype-independent
immunity, could help in the design of non-capsular pneumo-
coccal vaccines.
High pneumococcal density in the nasopharynx has been
linked to pneumococcal pneumonia and invasive pneumococcal
disease, and investigated as a potential diagnostic tool (Baggett
et al., 2017; Brotons et al., 2017). The present study provides new
insights into pneumococcal density during a carriage episode,
highlighting the fact that carriage is a dynamic process, affected
by multiple factors including antibiotic exposure and URTIs, as
well as the presence of co-colonizing pneumococcal serotypes. It
Table 4
Multivariable analysis of serotype-speciﬁc pneumococcal density during longer carriage episodes (detected in 3 swabs). The three-level model accounts for repeated
sampling and multiple serotype carriage, and included detection stage, age, antibiotic exposure, URTI symptoms, and multiple serotype carriage (n = 364).
Unadjusted coefﬁcienta
(95% CI)
p-Value Adjusted coefﬁcient
(95% CI)
p-Value
Stage of carriage episode
Initial Reference Reference
Middle 0.36 (0.59, 0.13) 0.002 0.35 (0.60, 0.09) 0.008
Final 0.65 (0.92, 0.38) <0.001 0.62 (0.99, 0.25) 0.001
URTI symptoms 0.06 (0.16, 0.28) 0.594 0.18 (0.04, 0.40) 0.106
Current antibiotic useb 0.90 (1.65, 0.15) 0.019 0.96 (1.70, 0.23) 0.010
Multiple serotype carriage 0.30 (0.56, 0.05) 0.020 0.27 (0.53, 0.02) 0.033
Age (months) 0.09 (0.14, 0.04) 0.001 0.01 (0.09, 0.07) 0.792
URTI, upper respiratory tract infection; CI, conﬁdence interval.
a Coefﬁcient is the difference in means (log10 genome equivalents/ml). See Table 3 footnote for further information on how to interpret the coefﬁcient.
b Antibiotic use at the time of swabbing.
Figure 5. Patterns of pneumococcal carriage dynamics. Representative examples, each from an individual study participant, are shown for the following patterns: (A) single
serotype carriage; (B) short-term co-colonization; (C) serotype replacement; (D) serotype dominance; (E) stable co-colonization. Serotype-speciﬁc pneumococcal carriage
density (in log10 genome equivalents/ml) is shown over time. Serotypes are labelled on the graph, with the ﬁrst acquisition shown in pink, second acquisition in green, third in
light blue, and fourth in dark blue.
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was found that multiple serotype carriage was associated with
higher overall pneumococcal carriage density by lytA qPCR, but
lower serotype-speciﬁc density in comparison to carriage of a
single pneumococcal serotype.
This study demonstrated that density during longer carriage
episodes tends to decrease over time. This observation is
consistent with a mouse model of pneumococcal carriage, in
which mice inoculated with a high dose of pneumococci displayed
decreasing pneumococcal density in the nasopharynx prior to
clearance (Neill et al., 2014). Bacterial characteristics may also
affect colonization density: a cross-sectional study reported that
pneumococcal density varies by serotype (Rodrigues et al., 2016).
However, studies that rely on a single sample to evaluate
pneumococcal density should be aware of the limitations of that
approach, particularly if they do not adjust for potential
confounding.
The main limitation of this study was the sampling time frame,
with monthly intervals between swab collection and an approxi-
mate 4-month gap prior to collection of the ﬁnal swab at 12
months of age. Short carriage episodes that occurred between
sampling points would not have been detected, so pneumococcal
acquisition was likely underestimated. As the ﬁrst swab was
collected at 2 months of age, it was not possible to determine an
accurate date of acquisition for the 44 participants who carried
pneumococcus at enrolment. Longitudinal carriage studies con-
ducted in The Gambia and South Africa collected swabs at birth and
twice a month thereafter, and are therefore a better source of data
on pneumococcal carriage in early infancy (Hill et al., 2008; Dube
et al., 2018).
Wider sampling time frames bias estimates of carriage duration
upwards, so this may in part explain why the median carriage
duration in this study (131 days) was longer than those reported in
studies with more frequent sampling from The Gambia (84 days),
Kenya (31 days), Thailand (31 days), and South Africa (30 days) (Hill
et al., 2008; Turner et al., 2012; Abdullahi et al., 2012; Dube et al.,
2018). The ability of our methods to detect secondary serotypes
present in lower abundance (as opposed to conventional methods
that typically detect a single serotype per sample) would have
increased the sensitivity of detection and also contributed to
longer estimates of carriage duration. We did not evaluate
serotype-speciﬁc differences in carriage duration due to small
numbers; however differences have been reported in studies from
Thailand and The Gambia (Hill et al., 2008; Turner et al., 2012).
Serotype, antimicrobial resistance, and prophage were found to be
associated with carriage duration in a large pneumococcal
genomics study (Lees et al., 2017).
No testing of viruses or detection of other colonizing bacteria
such as Haemophilus inﬂuenzae that can inﬂuence the density and
dynamics of pneumococcal carriage was conducted (Dunne et al.,
2018; Chien et al., 2013; Lewnard et al., 2016). The positive
association between URTI symptoms and pneumococcal carriage
rates and density observed in this study is consistent with several
studies reporting increased pneumococcal density during viral
URTIs (Vu et al., 2011; Morpeth et al., 2018). In children under 3
years old in rural Peru, pneumococcal densities peaked during
acute respiratory illness and were higher in children who tested
positive for a respiratory virus, particularly rhinovirus, compared
to those who were virus-negative (Fan et al., 2016). Interestingly,
DeMuri et al. recently demonstrated that pneumococcal densities
were higher in American children aged 4–7 years when a
respiratory virus was detected, regardless of whether the children
displayed URTI symptoms (DeMuri et al., 2018). HIV status was not
determined for mothers or infants in this study, but as the
prevalence of HIV in the general population of Indonesia is
estimated to be <0.5%, a similar low rate amongst participants was
assumed (Januraga et al., 2018).
The laboratory methods utilized in this study enabled
discrimination of different pneumococcal colonization pat-
terns. Carriage of a single serotype at a time was most common,
in line with epidemiological data and a mouse model
indicating that pneumococcal carriage inhibits the acquisition
of a second pneumococcal strain (Auranen et al., 2010; Lipsitch
et al., 2000). Recently, the competitive advantage of an
established pneumococcal strain against newcomers was
found to be dependent on the quorum sensing system (Shen
et al., 2019).
Within-host serotype replacement was observed; this may be
due to an immune-mediated reduction in density of the original
colonizing serotype that facilitates expansion of a more recently
acquired serotype and/or direct competition between pneumo-
coccal strains, which has been observed in experimental models
(Dawid et al., 2007; Wu et al., 2017).
As multiple serotype carriage was highest at 12 months in this
study, it would be interesting to examine co-colonization
dynamics in slightly older children. Larger sample sizes would
be required to examine the role of serotype in co-colonization
dynamics.
This study provides useful data on pneumococcal carriage
during infancy in Indonesia, with relevance to other moderate-
intensity carriage settings. Better understanding of how the
natural history of pneumococcal colonization affects subsequent
pneumococcal carriage episodes may help in the development of
vaccines that can harness the immunizing effects of colonization,
and also improve mathematical models of pneumococcal carriage.
The study ﬁndings highlight the dynamic nature of pneumococcal
carriage, particularly the changes in pneumococcal density that
can occur during a carriage episode.
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